Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer. | Ann Transl Med | 2021 | 34532389 | PubTator, text mining | PubMed |
| CHMP4C regulates lung squamous carcinogenesis and progression through cell cycle pathway. | J Thorac Dis | 2021 | 34527317 | PubTator, text mining | PubMed |
| Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition. | Toxicol Appl Pharmacol | 2021 | 34520793 | PubTator, text mining | PubMed |
| Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics. | J Biol Chem | 2021 | 34520756 | PubTator, text mining | PubMed |
| The roles of epigenetics in cancer progression and metastasis. | Biochem J | 2021 | 34520519 | PubTator, text mining | PubMed |
| RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers. | Front Oncol | 2021 | 34513691 | PubTator, text mining | PubMed |
| RNA Sequence Profiling Reveals Unique Immune and Metabolic Features of Breast Cancer Brain Metastases. | Front Oncol | 2021 | 34513670 | PubTator, text mining | PubMed |
| Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics. | Adv Pharm Bull | 2021 | 34513617 | PubTator, text mining | PubMed |
| Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression. | Cancers (Basel) | 2021 | 34503171 | PubTator, text mining | PubMed |
| Design and Analysis of an Active Reflection Controller That Can Reduce Acoustic Signal Refer to the Angle of Incidence. | Sensors (Basel) | 2021 | 34502684 | PubTator, text mining | PubMed |
| CG7379 and ING1 suppress cancer cell invasion by maintaining cell-cell junction integrity. | Open Biol | 2021 | 34493070 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| NOCICEPTRA: Gene and microRNA Signatures and Their Trajectories Characterizing Human iPSC-Derived Nociceptor Maturation. | Adv Sci (Weinh) | 2021 | 34486248 | PubTator, text mining | PubMed |
| The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis. | Front Immunol | 2021 | 34456908 | PubTator, text mining | PubMed |
| Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells. | Noncoding RNA | 2021 | 34449674 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special? | Cells | 2021 | 34440828 | PubTator, text mining | PubMed |
| Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context. | Biomedicines | 2021 | 34440098 | PubTator, text mining | PubMed |
| Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 34439391 | PubTator, text mining | PubMed |
| Designing of the N-ethyl-4-(pyridin-4-yl)benzamide based potent ROCK1 inhibitors using docking, molecular dynamics, and 3D-QSAR. | PeerJ | 2021 | 34434664 | PubTator, text mining | PubMed |
| Role of microRNAs in glioblastoma. | Oncotarget | 2021 | 34434499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=27